MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice

Nonalcoholic steatohepatitis (NASH) is the common liver disease characterized by hepatic steatosis, inflammation, and fibrosis; there are no approved drugs to treat this disease because of incomplete understanding of pathophysiological mechanisms of NASH. Milk fat globule-epidermal growth factor-fac...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Hu, Hui Du, Yinglin Yuan, Peipei Guo, Junxia Yang, Xinru Yin, Jin Liu, Shengwang Wu, Jingyuan Wan, Xia Gong
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/5791915
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558405963743232
author Jun Hu
Hui Du
Yinglin Yuan
Peipei Guo
Junxia Yang
Xinru Yin
Jin Liu
Shengwang Wu
Jingyuan Wan
Xia Gong
author_facet Jun Hu
Hui Du
Yinglin Yuan
Peipei Guo
Junxia Yang
Xinru Yin
Jin Liu
Shengwang Wu
Jingyuan Wan
Xia Gong
author_sort Jun Hu
collection DOAJ
description Nonalcoholic steatohepatitis (NASH) is the common liver disease characterized by hepatic steatosis, inflammation, and fibrosis; there are no approved drugs to treat this disease because of incomplete understanding of pathophysiological mechanisms of NASH. Milk fat globule-epidermal growth factor-factor 8 (MFG-E8), a multifunctional glycoprotein, has shown anti-inflammation and antifibrosis. Here, MFG-E8 was shown to play a key role in NASH progression. Using methionine and choline deficient (MCD) diet-fed mice, we found MFG-E8 knockout exacerbated hepatic damage and steatosis as indicated by increased plasma transaminases activities and hepatic histopathologic change, higher hepatic triglycerides (TGs), and lipid accumulation. Moreover, liver fibrosis and inflammation elicited by MCD were aggravated in MFG-E8 knockout mice. Mechanistically, MFG-E8 knockout facilitated activation of hepatic toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) signaling pathway in MCD-fed mice. In vitro experiment, the TLR4 specific antagonist TAK-242 rescued palmitic acid- (PA-) primed lipid formation and inflammation in MFG-E8 knockout primary murine hepatocytes. These findings indicated that MFG-E8 is involved in the progression of NASH and the possible mechanism by which MFG-E8 knockout exacerbated NASH in mice is associated with activation of the TLR4/NF-κB signaling pathway.
format Article
id doaj-art-ac57e950aa2b4b41b6eccd424d1654b4
institution Kabale University
issn 1466-1861
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-ac57e950aa2b4b41b6eccd424d1654b42025-02-03T01:32:34ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/5791915MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in MiceJun Hu0Hui Du1Yinglin Yuan2Peipei Guo3Junxia Yang4Xinru Yin5Jin Liu6Shengwang Wu7Jingyuan Wan8Xia Gong9Department of PharmacologyDepartment of PharmacologyClinical Immunology Translational Medicine Key Laboratory of Sichuan ProvinceDepartment of Clinical LaboratoryDepartment of PharmacologyDepartment of GastroenterologyDepartment of PharmacyDepartment of AnatomyDepartment of PharmacologyDepartment of AnatomyNonalcoholic steatohepatitis (NASH) is the common liver disease characterized by hepatic steatosis, inflammation, and fibrosis; there are no approved drugs to treat this disease because of incomplete understanding of pathophysiological mechanisms of NASH. Milk fat globule-epidermal growth factor-factor 8 (MFG-E8), a multifunctional glycoprotein, has shown anti-inflammation and antifibrosis. Here, MFG-E8 was shown to play a key role in NASH progression. Using methionine and choline deficient (MCD) diet-fed mice, we found MFG-E8 knockout exacerbated hepatic damage and steatosis as indicated by increased plasma transaminases activities and hepatic histopathologic change, higher hepatic triglycerides (TGs), and lipid accumulation. Moreover, liver fibrosis and inflammation elicited by MCD were aggravated in MFG-E8 knockout mice. Mechanistically, MFG-E8 knockout facilitated activation of hepatic toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) signaling pathway in MCD-fed mice. In vitro experiment, the TLR4 specific antagonist TAK-242 rescued palmitic acid- (PA-) primed lipid formation and inflammation in MFG-E8 knockout primary murine hepatocytes. These findings indicated that MFG-E8 is involved in the progression of NASH and the possible mechanism by which MFG-E8 knockout exacerbated NASH in mice is associated with activation of the TLR4/NF-κB signaling pathway.http://dx.doi.org/10.1155/2022/5791915
spellingShingle Jun Hu
Hui Du
Yinglin Yuan
Peipei Guo
Junxia Yang
Xinru Yin
Jin Liu
Shengwang Wu
Jingyuan Wan
Xia Gong
MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice
Mediators of Inflammation
title MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice
title_full MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice
title_fullStr MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice
title_full_unstemmed MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice
title_short MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice
title_sort mfg e8 knockout aggravated nonalcoholic steatohepatitis by promoting the activation of tlr4 nf κb signaling in mice
url http://dx.doi.org/10.1155/2022/5791915
work_keys_str_mv AT junhu mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice
AT huidu mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice
AT yinglinyuan mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice
AT peipeiguo mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice
AT junxiayang mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice
AT xinruyin mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice
AT jinliu mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice
AT shengwangwu mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice
AT jingyuanwan mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice
AT xiagong mfge8knockoutaggravatednonalcoholicsteatohepatitisbypromotingtheactivationoftlr4nfkbsignalinginmice